Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michele Freesmeier"'
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Aaron D. Bossler, Weizhou Zhang, Michele Freesmeier, Yousef Zakharia, Varun Monga, Umang Swami, Mohammed M. Milhem
Publikováno v:
Melanoma Res
Pembrolizumab is an effective therapy for patients with metastatic melanoma. However, not all patients derive benefit. It is postulated that an increase in regulatory T cells in melanoma patients can impair the response to immunotherapies. Continuous
Autor:
Hesham Yasin, Melanie Frees, Jaime Bonner, Mohammed M. Milhem, Vyshak Alva Venur, Rohan Garje, Jayanshu Jain, Yousef Zakharia, Michele Freesmeier
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background In the United States, melanoma is the fifth leading cancer in men and the seventh in women. Immunotherapy has improved antitumor activity and survival. Overall response rate (ORR) with single agent PD-1 inhibitor is 35%, and 55% with the c
Autor:
Michael D. Henry, Rithu Srikantha, Umang Swami, Yousef Zakharia, Marion Vanneste, Michele Freesmeier, Melanie Frees, Noah Frydenlund, Mirza Khan, Mohammed M. Milhem, Varun Monga, Aaron D. Bossler
Publikováno v:
Oncotarget
// Yousef Zakharia 1 , Varun Monga 1 , Umang Swami 1 , Aaron D. Bossler 4 , Michele Freesmeier 1 , Melanie Frees 1 , Mirza Khan 5 , Noah Frydenlund 2 , Rithu Srikantha 2 , Marion Vanneste 3 , Michael Henry 3 and Mohammed Milhem 1 1 Department of Hema
Autor:
Michael J. Goodheart, Jean Hansen, Anna M. Button, Jean-Marie Stephan, David Bender, Michele Freesmeier
Publikováno v:
Gynecologic oncology. 138(1)
Objective Many clinicians limit chemotherapy doses based on a maximum body surface area (BSA) of 2m 2 . We sought to determine how chemotherapy-related toxicities compared between groups of patients that varied with respect to BSA. We hypothesized th
Autor:
Jean-Marie Stephan, Anna M. Button, David Bender, Michael J. Goodheart, Jean M. Hansen, Michele Freesmeier
Publikováno v:
Gynecologic Oncology. 133:165-166
Autor:
Michele Freesmeier, Anna M. Button, Jean-Marie Stephan, Jean Hansen, Michael J. Goodheart, David Bender
Publikováno v:
Gynecologic Oncology. 134:433